These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9442183)

  • 21. Premorbid adjustment and neuropsychological performance in schizophrenia.
    Silverstein ML; Mavrolefteros G; Close D
    Schizophr Bull; 2002; 28(1):157-65. PubMed ID: 12047015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive impairments in schizophrenia and schizoaffective disorder: relationship with clinical characteristics.
    Torniainen M; Suvisaari J; Partonen T; Castaneda AE; Kuha A; Suokas J; Perälä J; Saarni SI; Lönnqvist J; Tuulio-Henriksson A
    J Nerv Ment Dis; 2012 Apr; 200(4):316-22. PubMed ID: 22456585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Six-year outcomes in first admission adolescent inpatients: clinical and cognitive characteristics at admission as predictors.
    Pogge DL; Insalaco B; Bertisch H; Bilginer L; Stokes J; Cornblatt BA; Harvey PD
    Psychiatry Res; 2008 Jul; 160(1):47-54. PubMed ID: 18534688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Social cognitive markers of short-term clinical outcome in first-episode psychosis.
    Montreuil T; Bodnar M; Bertrand MC; Malla AK; Joober R; Lepage M
    Clin Schizophr Relat Psychoses; 2010 Jul; 4(2):105-14. PubMed ID: 20643633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The longitudinal course of schizoaffective disorders. A prospective follow-up study.
    Grossman LS; Harrow M; Fudala JL; Meltzer HY
    J Nerv Ment Dis; 1984 Mar; 172(3):140-9. PubMed ID: 6699629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers.
    Liu SK; Chiu CH; Chang CJ; Hwang TJ; Hwu HG; Chen WJ
    Am J Psychiatry; 2002 Jun; 159(6):975-82. PubMed ID: 12042186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychological and symptom predictors of aggression on the psychiatric inpatient service.
    Serper M; Beech DR; Harvey PD; Dill C
    J Clin Exp Neuropsychol; 2008 Aug; 30(6):700-9. PubMed ID: 18608673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RBANS neuropsychological profiles within schizophrenia samples recruited from non-clinical settings.
    Loughland CM; Lewin TJ; Carr VJ; Sheedy J; Harris AW
    Schizophr Res; 2007 Jan; 89(1-3):232-42. PubMed ID: 17049816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of neurocognitive deficits in understanding adaptive functioning in severe psychiatric illness: commentary on Hawkins and Cooper.
    Nuechterlein KH; Subotnik KL
    Psychiatry; 1996; 59(4):389-92. PubMed ID: 9029660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The broad importance of cognitive impairments in aging-related disorders.
    Harvey PD
    Am J Geriatr Psychiatry; 2008 Feb; 16(2):99-101. PubMed ID: 18239194
    [No Abstract]   [Full Text] [Related]  

  • 32. Theory of mind performance in schizophrenia: diagnostic, symptom, and neuropsychological correlates.
    Greig TC; Bryson GJ; Bell MD
    J Nerv Ment Dis; 2004 Jan; 192(1):12-8. PubMed ID: 14718771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the modified WAIS-R with psychiatric inpatients: a caution.
    Boone D
    Percept Mot Skills; 1991 Aug; 73(1):315-22. PubMed ID: 1945712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychological functions predict 1- and 3-year outcome in first-episode psychosis.
    Carlsson R; Nyman H; Ganse G; Cullberg J
    Acta Psychiatr Scand; 2006 Feb; 113(2):102-11. PubMed ID: 16423161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clarifying the diversity of first-episode psychosis: Neuropsychological correlates of clinical symptoms.
    Lindsberg J; Poutiainen E; Kalska H
    Nord J Psychiatry; 2009 Nov; 63(6):493-500. PubMed ID: 19685368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of cognitive, behavioral, or emotional dysfunction in progressive muscular atrophy.
    Wicks P; Abrahams S; Leigh PN; Williams T; Goldstein LH
    Neurology; 2006 Nov; 67(9):1718-9. PubMed ID: 17101922
    [No Abstract]   [Full Text] [Related]  

  • 37. Personality traits and psychiatric rehospitalization: a two-year follow-up.
    Donat DC
    J Pers Assess; 1997 Jun; 68(3):703-11. PubMed ID: 9170305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurocognitive growth charting in psychosis spectrum youths.
    Gur RC; Calkins ME; Satterthwaite TD; Ruparel K; Bilker WB; Moore TM; Savitt AP; Hakonarson H; Gur RE
    JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of Mini-Mental State Examination (MMSE) in long-stay patients with schizophrenia or schizoaffective disorders in a psychiatric institute.
    Ong HL; Subramaniam M; Abdin E; Wang P; Vaingankar JA; Lee SP; Shafie S; Seow E; Chong SA
    Psychiatry Res; 2016 Jul; 241():256-62. PubMed ID: 27203153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating cognitive deficits and symptomatology across pre-morbid adjustment patterns in first-episode psychosis.
    Béchard-Evans L; Iyer S; Lepage M; Joober R; Malla A
    Psychol Med; 2010 May; 40(5):749-59. PubMed ID: 19732482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.